Amyloid
Amyloid is one of those things clinicians can put in many differential diagnoses. The pathologist can diagnose it.
Definition
- Disorder of protein folding - structure: beta sheet.[1]
Appearance
Light microscopy
Features:[2]
- Pink (on H&E stain).
- Extracellular location.
- Amorphous - no specific shape.
Stains:
Images:
- Amyloid - congo red stain - wikipedia.org.
- Amyloid - H&E stain - wikimedia.org.
Electron microscopy
Features:[5]
- Fine fibrils.
Images:
DDx
- CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy).
- Typically has basophilic granularity in the blood vessels.[6]
Associations - DDx
- Infections.[7][8]
- Tuberculosis.
- Leprosy.
- Chronic osteomyelitis.
- Bronchiectasis.
- Idiopathic conditions:
- Rheumatoid arthritis - relatively common (compared to others below).
- Anklyosing spondylitis - renal amyloidosis.
- Crohn's disease.[7]
- Familial Mediterranean fever.[7]
- Malignancy.
- Many other conditions...
Classification
Amyloidosis can be classified a number of different ways.
Six subtypes classification
Amyloid classified into six groups:[3]
- Primary (AL amyloidosis).
- Monoclonal light chains in serum and/or urine, may be due to plasma cell dyscrasia.
- Secondary (AA amyloidosis).
- Infections (osteomyelitis), neoplasia (Hodgkin's lymphoma).
- Hemodialysis-related.
- Beta-2 microglobulin.[10]
- Localized, e.g. Abeta amyloid found in Alzheimer's disease, pancreatic amyloid deposition associated with diabetes mellitus.[11]
- Hereditary.
- Senile systemic amyloidosis.
How to remember: Two As = secondary amyloidosis.
Three main types - Robbins classification
Amyloid classified into three groups:[1]
- AL amyloidosis - "AL" = Amyloid Light chain.[12]
- AA amyloidosis - "AA" = Amyloid Associated.[14]
- Secondary amyloidosis.
- Abeta amyloid - found in Alzheimer's disease.[15]
Additional types:
- ATTR = Amyloid Transthyretin (TTR)
- Transthyretin - serum protein that transport thyroxine and retinol; transthyretin AKA prealbumin.
Treatment
The very short version:
Classification of amyloid - differentiation
AA amyloidosis does not stain with congo red if pre-treated with potassium permanganate.[16] in other words,
References
- van Rijswijk MH, van Heusden CW (October 1979). "The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice". Am. J. Pathol. 97 (1): 43–58. PMC 2042379. PMID 495695. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042379/.
- Murphy CL, Eulitz M, Hrncic R, et al. (July 2001). "Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens". Am. J. Clin. Pathol. 116 (1): 135–42. doi:10.1309/TWBM-8L4E-VK22-FRH5. PMID 11447744.
- Murphy CL, Wang S, Williams T, Weiss DT, Solomon A (2006). "Characterization of systemic amyloid deposits by mass spectrometry". Meth. Enzymol. 412: 48–62. doi:10.1016/S0076-6879(06)12004-2. PMID 17046651.
- Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, Dogan A (December 2009). "Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens". Blood 114 (24): 4957–9. doi:10.1182/blood-2009-07-230722. PMID 19797517.
IHC
- Can be classified based on IHC.[17]
- Transthyretin - from transports thyroxine and retinol (previous prealbumin).
Secondary amyloidosis
- AKA AA amyloidosis.
- Pathophysiology: acute-phase reactant serum amyloid A (SAA) - degraded + deposits.[7][18]
Cardiac amyloidosis
General
- Common cause of restrictive cardiomyopathy.[19]
Cardiac amyloidosis - subtypes:
- AL amyloidosis - associated with plasma cell dyscrasia - most common cardiac amyloidosis.[20]
- Senile systemic amyloidosis - TTR-related amyloidosis (unmutated TTR).
- Hereditary amyloidosis.
- AA amyloidosis is uncommon.
Clinical:
- CHF, conduction abnormalities.
- Kidney disease (proteinuria) - associated with AL amyloidosis.
Senile systemic amyloidosis
- Abbreviated SSA.
- Previously known as senile cardiac amyloidosis.[21]
- May be referred to as ATTR = amyloidosis TTR; in SSA the TTR is not mutated.
- There is a hereditary form of amyloidosis with mutated TTR deposition known as ATTR type FAP = ATTR type Familial Amyloid Polyneuropahty.
Epidemiology:
- Common in the elderly, as the word senile suggests.
- Found in approx. 25% of elderly over 80 years old,[21] and in upto 65% of patients over 90 years old.[20]
Gross pathology:
- Grey/black "peppering" of left atrial endocardium - in fixed specimens.[22]
- "Peppering" should be present if severe.
Histology:
- Heart most commonly involved, followed by lungs and then by kidney (renal papilla).
- DDx of pink of H&E is important to remember: amyloid, muscle, collagen, clotted blood.
- Amyloid vs. Fibrosis? Subendocardial fibrosis may have rim of (diffusion) preserved myocytes. (???)
- Amyloid often present in the subepicardial tissue[20] - less commonly affected by ischemia.
Treatment:
- No effective treatment.
Images:
- Senile systemic amyloidosis - H&E (wikimedia.org).
- Senile systemic amyloidosis - congo red (wikimedia.org).
- Senile systemic amyloidosis - Movat's (wikimedia.org).
Renal amyloidosis
Both AL and AA amyloidosis can affect the kidney.[4]
GI amyloidosis
GI amyloidosis can lead to obstruction and usually is greatest in the small bowel.[3]
Liver amyloidosis
Features:
- Parenchymal deposition (common).
- Portal triad deposition (less common).
See also
References
- ↑ 1.0 1.1 Lachmann HJ, Hawkins PN (2006). "Amyloidosis and the lung". Chron Respir Dis 3 (4): 203-14. PMID 17190124. http://crd.sagepub.com/cgi/pmidlookup?view=long&pmid=17190124.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 259. ISBN 0-7216-0187-1.
- ↑ 3.0 3.1 3.2 3.3 3.4 Ebert EC, Nagar M (March 2008). "Gastrointestinal manifestations of amyloidosis". Am. J. Gastroenterol. 103 (3): 776-87. doi:10.1111/j.1572-0241.2007.01669.x. PMID 18076735.
- ↑ 4.0 4.1 Nishi S, Alchi B, Imai N, Gejyo F (April 2008). "New advances in renal amyloidosis". Clin. Exp. Nephrol. 12 (2): 93-101. doi:10.1007/s10157-007-0008-3. PMID 18175051.
- ↑ 5.0 5.1 URL: http://www.fondazionedamico.org/biopsiarenale_atlas/seco/amil/amil21.htm. Accessed on: 9 November 2010.
- ↑ Kleinschmidt-DeMasters BK, Prayson RA (November 2006). "An algorithmic approach to the brain biopsy--part I". Arch. Pathol. Lab. Med. 130 (11): 1630–8. PMID 17076524.
- ↑ 7.0 7.1 7.2 7.3 7.4 7.5 Amyloidosis. Merck Manual. URL: http://www.merck.com/mmpe/sec12/ch160/ch160a.html. Accessed on: 3 December 2009.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 261. ISBN 0-7216-0187-1.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 261. ISBN 0-7216-0187-1.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 260. ISBN 0-7216-0187-1.
- ↑ URL: http://www.umm.edu/altmed/articles/amyloidosis-000007.htm. Accessed on: 23 October 2010.
- ↑ Comenzo, RL.; Vosburgh, E.; Falk, RH.; Sanchorawala, V.; Reisinger, J.; Dubrey, S.; Dember, LM.; Berk, JL. et al. (May 1998). "Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.". Blood 91 (10): 3662-70. PMID 9573002.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 261. ISBN 0-7216-0187-1.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 259. ISBN 0-7216-0187-1.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 259. ISBN 0-7216-0187-1.
- ↑ van Rijswijk MH, van Heusden CW (October 1979). "The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice". Am. J. Pathol. 97 (1): 43–58. PMC 2042379. PMID 495695. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042379/.
- ↑ Röcken C (December 2009). "[Update on immunohistological classification of amyloidoses]" (in German). Pathologe 30 Suppl 2: 121–3. doi:10.1007/s00292-009-1183-7. PMID 19756621.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 260. ISBN 0-7216-0187-1.
- ↑ Cardiac amyloidosis. Medlineplus.org. URL: http://www.nlm.nih.gov/medlineplus/ency/article/000193.htm. Accessed on: 3 December 2009.
- ↑ 20.0 20.1 20.2 Sharma, PP.; Payvar, S.; Litovsky, SH.. "Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium.". Cardiovasc Pathol 17 (2): 65-71. doi:10.1016/j.carpath.2007.05.008. PMID 18329550.
- ↑ 21.0 21.1 Ikeda, S. (Dec 2004). "Cardiac amyloidosis: heterogenous pathogenic backgrounds.". Intern Med 43 (12): 1107-14. PMID 15645642.
- ↑ Pomerance, A. (Sep 1965). "Senile cardiac amyloidosis.". Br Heart J 27 (5): 711-8. PMID 5829755. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC469777/pdf/brheartj00340-0085.pdf.
External links
- Amyloidosis - wikipedia.org.